Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.
By christian Biomet, a major manufacturer of artificial hips and knees, said on December 18th that it had agreed to a $10.9 billion buyout offer from a private investment consortium.
The bid came from affiliates of the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Company and the Texas Pacific Group. Biomet said the private investment group was also expected to include Dane A. Miller, a co-founder of Biomet in 1977 and its longtime chief executive until he resigned in April, citing disagreements with the board.
By Andrea Weidner Kleinostheim, Germany, September 4th, 2009 – curasan AG, listed on the General Standard of Deutsche Börse AG as ISIN: DE 000 549 453 8, has just received a grant of €1.48 million from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) for a bone regeneration research project scheduled to last three years. The funds are earmarked for a joint project with Ben Gurion University (BGU) of the Negev, Israel.
By Bianka Wolf
By Paula Rutledge
By Jenn Giusti
By Bianka Jerke
By Bianka Jerke
By Bianka Jerke
By Bianka Jerke
By Katherine Dec 
StelKast is proud to announce the recent FDA 510(k) clearance of their
new EXpTM Acetabular Liners. EXpTM, a blend of antioxidant and highly
cross-linked polyethylene technology was developed with the consulting
support of Steven Kurtz, Ph.D. and Exponent, Inc. (Philadelphia, PA).
StelKast has also received 510(k) clearance for large diameter
cobalt-chrome femoral heads and Biolox® delta femoral heads.
Page 27 of 27
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.